KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Debt to Equity (2016 - 2025)

AbbVie (ABBV) has disclosed Debt to Equity for 14 consecutive years, with -$19.03 as the latest value for Q4 2025.

  • Quarterly Debt to Equity fell 194.25% to -$19.03 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$19.03 through Dec 2025, down 194.25% year-over-year, with the annual reading at -$19.03 for FY2025, 194.25% down from the prior year.
  • Debt to Equity for Q4 2025 was -$19.03 at AbbVie, up from -$24.58 in the prior quarter.
  • The five-year high for Debt to Equity was $45.23 in Q1 2025, with the low at -$470.72 in Q2 2025.
  • Average Debt to Equity over 5 years is -$17.99, with a median of $4.76 recorded in 2022.
  • Peak annual rise in Debt to Equity hit 391.81% in 2025, while the deepest fall reached 4645.63% in 2025.
  • Over 5 years, Debt to Equity stood at $4.16 in 2021, then decreased by 12.01% to $3.66 in 2022, then soared by 56.06% to $5.71 in 2023, then surged by 253.55% to $20.19 in 2024, then plummeted by 194.25% to -$19.03 in 2025.
  • According to Business Quant data, Debt to Equity over the past three periods came in at -$19.03, -$24.58, and -$470.72 for Q4 2025, Q3 2025, and Q2 2025 respectively.